Resources Investment Advisors, Llc. Axsome Therapeutics, Inc. Transaction History

Resources Investment Advisors, Llc.

$8.43 Billion
Q3 2024

A detailed history of Resources Investment Advisors, Llc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 8,735 shares of AXSM stock, worth $760,032. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,735

Previous 8,819 0.95%

Holding current value

$760,032

Previous $709,000 10.58%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$78.93 - $95.84 $6,630 - $8,050	-84 Reduced 0.95%	8,735 $784,000
Q2 2024 Aug 02, 2024	BUY	$65.72 - $80.5 $47,449 - $58,121	722 Added 8.92%	8,819 $709,000
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $22,551 - $31,733	325 Added 4.18%	8,097 $646,000
Q4 2023 Feb 13, 2024	SELL	$57.42 - $83.61 $8,038 - $11,705	-140 Reduced 1.77%	7,772 $618,000
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $126,589 - $150,279	-1,828 Reduced 18.77%	7,912 $552,000
Q2 2023 Aug 07, 2023	BUY	$58.41 - $90.35 $2,044 - $3,162	35 Added 0.36%	9,740 $699,000
Q1 2023 May 10, 2023	BUY	$58.39 - $75.0 $94,650 - $121,575	1,621 Added 20.05%	9,705 $598,000
Q4 2022 Feb 02, 2023	SELL	$39.94 - $79.72 $56,994 - $113,760	-1,427 Reduced 15.0%	8,084 $623,000
Q3 2022 Nov 08, 2022	BUY	$36.06 - $69.85 $1,117 - $2,165	31 Added 0.33%	9,511 $424,000
Q2 2022 Aug 08, 2022	SELL	$21.74 - $46.75 $152 - $327	-7 Reduced 0.07%	9,480 $363,000
Q1 2022 May 05, 2022	SELL	$23.7 - $41.39 $5,451 - $9,519	-230 Reduced 2.37%	9,487 $393,000
Q4 2021 Feb 23, 2022	SELL	$30.7 - $43.36 $6,754 - $9,539	-220 Reduced 2.21%	9,717 $367,000
Q3 2021 Nov 05, 2021	BUY	$19.91 - $68.26 $61,183 - $209,762	3,073 Added 44.77%	9,937 $327,000
Q2 2021 Aug 09, 2021	BUY	$50.63 - $73.5 $36,605 - $53,140	723 Added 11.77%	6,864 $463,000
Q1 2021 May 10, 2021	BUY	$55.91 - $81.44 $20,351 - $29,644	364 Added 6.3%	6,141 $347,000
Q4 2020 Feb 08, 2021	BUY	$66.31 - $86.52 $114,318 - $149,160	1,724 Added 42.54%	5,777 $470,000
Q3 2020 Oct 09, 2020	BUY	$68.34 - $85.84 $276,982 - $347,909	4,053 New	4,053 $288,000
Q3 2019 Nov 08, 2019	SELL	$20.24 - $29.16 $3,035 - $4,374	-150 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.46 - $25.75 $2,019 - $3,862	150 New	150 $0

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.

Account

Resources Investment Advisors, Llc. Axsome Therapeutics, Inc. Transaction History